MD MEDNAX Inc.

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

The Company will present on Monday, November 7, 2016 at 10:00 a.m. MT to investors attending the Credit Suisse 25th Annual Healthcare Conference in Scottsdale.

MEDNAX will also present on Tuesday, November 15, 2016 at 11:45 a.m. ET to investors attending the Stifel 2016 Healthcare Conference in New York.

The presentations will be broadcast through a live audio webcast and will be available for replay at www.mednax.com/investors.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,600 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.

EN
02/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 27,600 shares at 15.350USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch